2016 Top Market Report on Glaucoma Treatment Industrial Report with Worldwide Research, Demand, Valuable Forecast 2021
Description-
The
report titled “Global Glaucoma
Treatment
Market: Trends and Opportunities (2014-2019)” provides an insight
into the glaucoma treatment market over the years with a special
focus on major categories- pharmaceuticals and devices. The report
includes detailed information on market size and share by type of
drugs in glaucoma treatment sector. It also discusses key growth
drivers, challenges and trends of the market. Further, companies like
Pfizer Inc, Merck & Co, Allergan Inc and Alcon (Division of
Novartis) are profiled in the report.
Countries
Coverage
- The US
- Japan
Company
Coverage
- Pfizer Inc,
- Merck & Co,
- Allergan Inc and
- Alcon (Division of Novartis)
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-glaucoma-treatment-market-trends-and-opportunities-2014-2019-report.html
Executive
Summary
Glaucoma,
the second most common cause of blindness worldwide is generally
characterized by relatively high intraocular pressure (IOP) as a
result of impaired drainage of fluid, known as aqueous humor, from
the eye. Currently approved treatments for glaucoma include a number
of pharmaceutical drugs, laser therapies and surgical procedures.
Glaucoma treatment forms a significant portion of the overall eye
care market.
The
market for glaucoma treatment has grown rapidly in the last decade,
based on both increasing number of people with glaucoma and the
introduction of new treatments. However, the worldwide glaucoma
treatment market is expected to decline that can be attributable to
price reduction of drugs due to generic availability of many brands
in coming years.
The
glaucoma pharmaceuticals are segmented into two classes namely
prostaglandins analogues (PGAs) and Non PGAs that include beta
blockers, carbonic anhydrase inhibitors and alpha agonists. PGAS are
the most widely prescribed drug class for glaucoma with latanoprost
(brand name Xalatan) the most commonly prescribed drug.
Key
growth drivers of the market include rising ageing population,
healthcare expenditures, medical coverage and new innovative
combination drugs. The market players in medication as well as
devices segments are totally different and somewhat very fragmented.
Leaders in glaucoma medication space include Pfizer Inc, Alcon Inc.
(Novartis), Allergan Inc and Merck and Co, Inc. Companies developing
glaucoma drug-delivery devices include Ocular Therapeutix Inc, QLT
Inc, pSivida Corp, Icon Bioscience Inc, Amorphex Therapeutics LLC,
Euclid Systems Corp and Replenish Inc. In glaucoma laser market, top
market leaders include Ellex, Lumenis, Quantel and Lightmed.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment